CGEM
Cullinan Oncology Inc

424
Mkt Cap
$730.18M
Volume
1.38M
52W High
$13.33
52W Low
$5.68
PE Ratio
-3.39
CGEM Fundamentals
Price
$12.46
Prev Close
$12.36
Open
$12.77
50D MA
$8.63
Beta
1.09
Avg. Volume
1.18M
EPS (Annual)
-$3.11
P/B
1.63
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Cullinan Therapeutics (NASDAQ:CGEM) Price Target Raised to $34.00
Wedbush raised their price objective on Cullinan Therapeutics from $25.00 to $34.00 and gave the stock an "outperform" rating in a research note on Tuesday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Trading 9.3% Higher - What's Next?
Cullinan Therapeutics (NASDAQ:CGEM) Trading 9.3% Higher - Here's Why...
MarketBeat·2d ago
News Placeholder
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Consensus Recommendation of "Moderate Buy" by Analysts
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports...
MarketBeat·5d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 7.3% - What's Next?
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 7.3% - Here's What Happened...
MarketBeat·8d ago
News Placeholder
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells 4,000 Shares of Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 4,000 shares of Cullinan Therapeutics stock in a transaction dated Monday, November 24th. The shares were...
MarketBeat·14d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Trading Down 7.6% - Should You Sell?
Cullinan Therapeutics (NASDAQ:CGEM) Trading Down 7.6% - Should You Sell...
MarketBeat·14d ago
News Placeholder
Foresite Capital Management VI LLC Lowers Stock Position in Cullinan Therapeutics, Inc. $CGEM
Foresite Capital Management VI LLC reduced its position in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Free Report) by 6.4% during the second quarter, according to its most recent disclosure...
MarketBeat·15d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Sees Large Volume Increase - Should You Buy?
Cullinan Therapeutics (NASDAQ:CGEM) Sees Large Volume Increase - Here's Why...
MarketBeat·15d ago
News Placeholder
Investors Purchase High Volume of Call Options on Cullinan Therapeutics (NASDAQ:CGEM)
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) was the target of unusually large options trading activity on Monday. Investors acquired 2,185 call options on the stock. This represents...
MarketBeat·16d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded shares of Cullinan Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·19d ago

Latest CGEM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.